U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX1078696: GSM1753022: Alzheimer's Brain Sample64; Homo sapiens; RNA-Seq
2 ILLUMINA (Illumina HiSeq 2500) runs: 2M spots, 249.7M bases, 181Mb downloads

Submitted by: Gene Expression Omnibus (GEO)
Study: UTRseq_human_brain
show Abstracthide Abstract
Alternative polyadenylation (APA) contributes to post-transcriptional regulation, but its role in Alzheimer's disease (AD) is largely unknown. Using high-resolution SQUARE multiple 3' primer-based sequencing, we discovered massive APA differences in temporal gyrus tissues from demented AD patients compared to either healthy controls or non-demented donors with AD neuropathology (NDWP). Advanced statistics, microfluidics RT-PCR and protein measurements validated known and novel APA-modified 3'-intact transcripts. Moreover, APA modifications, more than total transcript counts, distinguished AD patients from both controls and NDWP donors and identified cell type-characteristic, cognition-associated and neuropathology-related changes. AD-enhanced APA variants included known therapeutic targets of brain, vascular and autoimmune disorders, predicting co-involvement of these target genes in AD progression; AD/NDWP increases in 3'-intact proteinopathy-related hnRNP mRNAs were inversely associated with protein decreases, whereas NDWP-potentiated cognition was accompanied by distinct ATP and mitochondrial variants. APA variations thus provide a novel resource of unique value for both basic and translational neuroscience researchers. Overall design: Examination of polyadenylation sites in brain tissues of Alzheimer`s disease patients, with 3 levels of pathology and 3 levels of cognition
Sample: Alzheimer''s Brain Sample64
SAMN03835335 • SRS976934 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: RNA was extracted with the SPLIT RNA extraction kit (Lexogen GmbH, Vienna, Austria) yielding the large RNA fraction with a lower cut-off size of 150 nt. Evaluation on a Bioanalyzer RNA Nano chip (Agilent Technologies) showed medium to high RNA quality (RIN of 6.2 – 8.3). 4 µg RNA was incubated with Terminator 5´-phosphate-dependent exonuclease (Epicentre, Madison, WI, USA) to remove degraded RNA while leaving the capped, full-length mRNA intact Per sample, 20 ng of the purified full-length total RNA were used for performing the 3’ QuantSeq Reverse protocol (Lexogen GmbH, Vienna, Austria) resulting in NGS libraries which originate from the 3’ end of polyadenylated RNA. Library generation was started by oligo(dT) priming with primers already containing the Illumina-compatible linker sequence for Read 1. After first strand synthesis the RNA was removed before the second strand synthesis was initiated by random primers which contained the corresponding Illumina-compatible linker sequence. 3’ QuantSeq generated just one fragment per transcript at the very 3’ end. The libraries were PCR amplified and barcoded in 18 cycles. Equal amounts of the 72 libraries were combined to one lane mixture.
Experiment attributes:
GEO Accession: GSM1753022
Links:
Runs: 2 runs, 2M spots, 249.7M bases, 181Mb
Run# of Spots# of BasesSizePublished
SRR20842921,008,564127.3M92.5Mb2017-08-02
SRR2084293967,972122.4M88.5Mb2017-08-02

ID:
1580042

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...